Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03SUI
|
||||
Former ID |
DNC010406
|
||||
Drug Name |
Pyridin-3-yl 4-butoxybenzylcarbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H20N2O3
|
||||
Canonical SMILES |
CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CN=CC=C2
|
||||
InChI |
1S/C17H20N2O3/c1-2-3-11-21-15-8-6-14(7-9-15)12-19-17(20)22-16-5-4-10-18-13-16/h4-10,13H,2-3,11-12H2,1H3,(H,19,20)
|
||||
InChIKey |
CZFYUEMAFQHRFG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.